NASDAQ:TSHA | Operating Income | Taysha Gene Therapies, Inc.

Complete source-backed operating income history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$47.35M
2026-03-31-$43.49M
2025-12-31-$28.3M
2025-09-30-$34.02M
2025-06-30-$26.75M
2025-03-31-$21.42M
2024-12-31-$19.93M
2024-09-30-$25.9M
2024-06-30-$21.3M
2024-03-31-$24.33M
2023-12-31-$16.25M
2023-09-30-$16.25M
2023-06-30-$23.38M
2023-03-31-$16.56M
2022-12-31-$53.97M
2022-09-30-$25.46M
2022-06-30-$33.37M
2022-03-31-$49.65M
2021-12-31-$49.72M
2021-09-30-$50.68M
2021-06-30-$40.77M
2021-03-31-$32.09M
2020-12-31-$18.37M
2020-09-30-$15.04M
2020-06-30-$4.01M
2020-03-31-$5.58M

Annual Operating Income

DateOperating Income
2025-12-31-$110.5M
2024-12-31-$91.46M
2023-12-31-$72.44M
2022-12-31-$162.45M
2021-12-31-$173.27M
2020-12-31-$43M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.